Re: Reports of Exempt Distribution

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Toinv

Rank: President [?]

Points: 4445 [?]

Votes: 35 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Reports of Exempt Distribution

in response to

Re: Reports of Exempt Distribution

KOO-KOO2

posted on Feb 22, 2023 09:43AM

Hi koo.

Just a quick note to thank you for keeping us informed of the financings. They do give us clues about what this "mushroom management" company is up too.

GLTA

Toinv

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply